ArticleOncology and therapy2021

A Real-World Evidence Study of CDK4/6 Inhibitor Treatment Patterns and Outcomes in Metastatic Breast Cancer by Germline BRCA Mutation Status.

Jenna M Collins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.